SB1773 - 104th General Assembly
| |||||||
| |||||||
| 1 | AMENDMENT TO SENATE BILL 1773 | ||||||
| 2 | AMENDMENT NO. ______. Amend Senate Bill 1773 on page 1, | ||||||
| 3 | line 5, by inserting "and by adding Section 309.1" after | ||||||
| 4 | "208"; and | ||||||
| 5 | on page 102 by inserting immediately below line 10 the | ||||||
| 6 | following: | ||||||
| 7 | "(720 ILCS 570/309.1 new) | ||||||
| 8 | Sec. 309.1. Xylazine exemptions. Notwithstanding the | ||||||
| 9 | scheduling of xylazine as a Schedule III controlled substance, | ||||||
| 10 | xylazine shall not be considered a controlled substance when: | ||||||
| 11 | (1) used by licensed Illinois veterinarians dispensing | ||||||
| 12 | or prescribing for, or administering to, a nonhuman | ||||||
| 13 | species of a dronabinol (synthetic) in sesame oil and drug | ||||||
| 14 | containing xylazine that has been approved by the U.S. | ||||||
| 15 | Food and Drug Administration; | ||||||
| 16 | (2) used by licensed Illinois veterinarians dispensing | ||||||
| |||||||
| |||||||
| 1 | or prescribing for, or administering to, a nonhuman | ||||||
| 2 | species that is permissible under the Federal Food, Drug, | ||||||
| 3 | and Cosmetic Act; | ||||||
| 4 | (3) manufactured, distributed, or used as an active | ||||||
| 5 | pharmaceutical ingredient for manufacturing an animal drug | ||||||
| 6 | approved under the Federal Food, Drug, and Cosmetic Act; | ||||||
| 7 | (4) used by a licensed certified euthanasia technician | ||||||
| 8 | employed by a certified euthanasia agency; or | ||||||
| 9 | (5) used by a wildlife biologist engaged in legal or | ||||||
| 10 | authorized fieldwork under the indirect supervision of a | ||||||
| 11 | veterinarian.". | ||||||
